MedPath

Case Management Dyad

Not Applicable
Recruiting
Conditions
HIV
Pre-exposure Prophylaxis
Case Management
Registration Number
NCT06162897
Lead Sponsor
University of Chicago
Brief Summary

The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of individuals living with HIV who are virally suppressed (viral suppression) when compared to routine Ryan White Non-Medical Case Management.

Detailed Description

The purpose of this research is to test the impact of dyadic, focused case management on financial well-being, access to food, linkage to and retention in care outcomes for individuals living with or vulnerable to HIV. The study population is men who have sex with men (MSM) or same-sex attraction, gender-diverse persons, and cis-gender women living with or at increased vulnerability to HIV.

The study team will be testing the hypotheses that dyadic case management that is focused on financial wellness, will have better outcomes for folks living with or vulnerable to HIV. Analyses will be used to assess the efficacy of the intervention as an emerging practice.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Financial wellbeing18 months

Proportion of subjects who report improved financial wellbeing (e.g. consistent income, ability to pay bills).

Food Security18 months

Proportion of individuals who report improved access to food (e.g. fewer gaps in access to food, reduced concern about access to food).

Secondary Outcome Measures
NameTimeMethod
PrEP Persistence18 months

Proportion of individuals who have engaged in PrEP care regularly (beyond 6 months).

Viral Suppression18 months

Proportion of individuals who have a viral load below 200 copies/mL

Trial Locations

Locations (1)

University of Chicago

🇺🇸

Chicago, Illinois, United States

University of Chicago
🇺🇸Chicago, Illinois, United States
Rebecca Eavou, AM
Contact
231-357-5995
reavou@bsd.uchicago.edu
John A Schneider, MD, MPH
Principal Investigator
Alida Bouris, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.